Deprescribing is the process of withdrawing or replacing medications to improve outcomes and reduce medication-associated risks. Deprescribing, though traditionally the domain of healthcare professionals, is now receiving attention from human factors experts. In turn, the deprescribing community is gaining an appreciation for human-centered design and research. This panel gathers experts in human factors and pharmacy to critically discuss past, current, and future work concerning human-centered design and research in deprescribing. The panel will help formulate the value proposition for human factors in this important area.
Get full access to this article
View all access options for this article.
References
1.
AbebeE.CampbellN. L.ClarkD. O.TuW.HillJ. R.HarringtonA. B.. . . HoldenR. J. (2020). Reducing Anticholinergic Medication Exposure among Older Adults using Consumer Technology: Protocol for a Randomized Clinical Trial. Research in Social and Administrative Pharmacy, doi.org/10.1016/j.sapharm.2020.1010.1010.
2.
BarnettN.JubraiB. (2017). A themed journal issue on deprescribing. European Journal of Hospital Pharmacy, 24(1), 1–2.
3.
BataldenM.BataldenP.MargolisP.SeidM.ArmstrongG.Opipari-ArriganL.HartungH. (2016). Coproduction of healthcare service. BMJ Quality and Safety, 25(7), 509–517.
4.
BaumgartnerA.KunkesT.ClarkC. M.BradyL. A.MonteS. V.SinghR.. . . ChenH.-Y. W. (2020). Opportunities and Recommendations for Improving Medication Safety: Understanding the Medication Management System in Primary Care Through an Abstraction Hierarchy. JMIR Human Factors, 7(3), e18103.
5.
BoothJ.Lorimer MoseleyG.SchiltenwolfM.CashinA.DaviesM.HubscherM. (2017). Exercise for chronic musculoskeletal pain: A biopsychosocial approach. Musculoskeletal Care, 15(4), 413–421.
6.
BoustaniM. A.CampbellN. L.KhanB. A.AbernathyG.ZawahiriM.CampbellT.. . . CallahanC. M. (2012). Enhancing care for hospitalized older adults with cognitive impairment: a randomized controlled trial. Journal of General Internal Medicine, 27(5), 561–567.
7.
BrandtN. J. (2016). Optimizing Medication Use Through Deprescribing: Tactics for This Approach. Journal of Gerontological Nursing, 42(1), 10–14. https://doi.org/10.3928/00989134-20151218-08
8.
BrodyA. A.GibsonB.Tresner-KirschD.KramerH.ThraenI.CoarrM. E.RupperR. (2016). High Prevalence of Medication Discrepancies Between Home Health Referrals and Centers for Medicare and Medicaid Services Home Health Certification and Plan of Care and Their Potential to Affect Safety of Vulnerable Elderly Adults. Journal of the American Geriatrics Society, 64(11), e166–e170.
9.
CampbellN. L.HoldenR. J.BoustaniM. A. (2019). Preventing Alzheimer Disease by Deprescribing Anticholinergic Medications. JAMA Internal Medicine, 179(8), 1093–1094.
10.
CampbellN. L.HoldenR. J.TangQ.BoustaniM. A.TealE.HillstromJ.. . . CallahanC. M. (in press). Multi-component behavioral intervention to reduce exposure to anticholinergics in primary care older adults. Journal of the American Geriatrics Society.
11.
CampbellN. L.PerkinsA. J.KhanB. A.GaoS.FarberM. O.KhanS.. . . BoustaniM. A. (2019). Deprescribing in the pharmacologic management of delirium: a randomized trial in the Intensive Care Unit. Journal of the American Geriatrics Society, 67(4), 695–702.
12.
CarayonP.WooldridgeA.HoseB.-Z.SalweiM.BenneyanJ. (2018). Challenges And Opportunities For Improving Patient Safety Through Human Factors And Systems Engineering. Health Affairs, 37(11), 18621869.
13.
ClarkC. M.LaValleyS. A.SinghR.MustafaE.MonteS. V.WahlerR. GJr. (2020). A pharmacist-led pilot program to facilitate deprescribing in a primary care clinic. Journal of the American Pharmacists Association, 60(1), 105–111.
FarrellB.ManginD. (2019). Deprescribing Is an Essential Part of Good Prescribing. American Family Physician, 99(1), 7–9.
16.
HiltonL.HempelS.EwingB. A.ApaydinE.XenakisL.NewberryS.ColaiacoB.MaherA. R.ShanmanR. M.SorberoM. E.MaglioneM. A. (2017). Mindfulness Meditation for Chronic Pain: Systematic Review and Meta-analysis. Annals of Behavioral Medicine, 51(2), 199–213.
17.
HoldenR. J. (2020). A simplified system usability scale (SUS) for cognitively impaired and older adults. Proceedings of the International Symposium on Human Factors and Ergonomics in Health Care, 9(1), 180–182.
18.
HoldenR. J.AbebeE. (2021). Medication transitions: Vulnerable periods of change in need of human factors and ergonomics. Applied Ergonomics, 90, 103279.
19.
HoldenR. J.AbebeE.Russ-JaraA. L.ChuiM. A. (in press). Human factors and ergonomics methods for pharmacy research and clinical practice. Research in Social and Administrative Pharmacy. Doi: 10.1016/j.sapharm.2021.04.024
20.
HoldenR. J.CarayonP. (in press). SEIPS 101 and seven simple SEIPS tools. BMJ Quality & Safety. Doi:10.1136/bmjqs-2020-012538.
21.
HoldenR. J.SrinivasP.CampbellN. L.ClarkD. O.BodkeK. S.HongY.. . . CallahanC. M. (2019). Understanding older adults' medication decision making and behavior: A study on over-the-counter (OTC) anticholinergic medications. Research in Social & Administrative Pharmacy, 15, 53–60.
22.
KhanB. A.PerkinsA. J.CampbellN. L.GaoS.FarberM. O.WangS.. . . BoustaniM. A. (2019). Pharmacological management of delirium in the intensive care unit: a randomized pragmatic clinical trial. Journal of the American Geriatrics Society, 67(5), 1057–1065.
KleinH. A.MeiningerA. R. (2004). Self-management of medication and diabetes: cognitive control. IEEE Trans Syst Man Cybern Pt-A Syst Humans, 34(6), 718–725.
25.
KönigI. R.FuchsO.HansenG.von MutiusE.KoppM. V. (2017). What is precision medicine?The European Respiratory Journal, 50(4), 1700391.
26.
MakaryM. A.OvertonH. N.WangP. (2017). Overprescribing is major contributor to opioid crisis. BMJ, 359, j4792.
27.
MayC.MontoriV. M.MairF. S. (2009). We need minimally disruptive medicine. BMJ, 339, b2803.
28.
McGrathK.HajjarE. R.KumarC.HwangC.SalzmanB. (2017). Deprescribing: A simple method for reducing polypharmacy. Journal of Family Practice, 66(7), 436–445.
29.
O'MahonyD.O'SullivanD.ByrneS.O'ConnorM. N.RyanC.GallagherP. (2015). STOPP/START criteria for potentially inappropriate prescribing in older people: version 2. Age & Ageing, 44(2), 213–218.
30.
PerryS. J.CatchpoleK.RiveraA. J.ParkerS. H.GosbeeJ. (2021). ‘Strangers in a strange land’: Understanding professional challenges for human factors/ergonomics and healthcare. Applied Ergonomics, 94, 103040.
31.
PersellS. D.KarmaliK. N.LazarD.FriesemaE. M.LeeJ. Y.RademakerA.KaiserD.EderM.FrenchD. D.BrownT.WolfM. S. (2018). Effect of Electronic Health Record-Based Medication Support and Nurse-Led Medication Therapy Management on Hypertension and Medication Self-management: A Randomized Clinical Trial. JAMA Internal Medicine, 178(8), 1069–1077.
32.
PuleddaF.ShieldsK. (2018). Non-Pharmacological Approaches for Migraine. Neurotherapeutics, 15(2), 336–345.
33.
ReeveE.GnjidicD.LongJ.HilmerS. (2015). A systematic review of the emerging definition of “deprescribing” with network analysis: Implications for future research and clinical practice. British Journal of Clinical Pharmacology, 80(6), 1254–1268.
34.
ReeveE.WolffJ. L.SkehanM.BaylissE. A.HilmerS. N.BoydC. M. (2018). Assessment of Attitudes Toward Deprescribing in Older Medicare Beneficiaries in the United States. JAMA Internal Medicine, 178(12), 1673–1680.
ScottI. A.HilmerS. N.ReeveE.PotterK.Le CouteurD.RigbyD.GnjidicD.Del MarC. B.RougheadE. E.PageA.JansenJ.MartinJ. H. (2015). Reducing inappropriate polypharmacy: the process of deprescribing. JAMA Internal Medicine, 175(5), 827–834.
37.
StantonN. A.YoungM. S. (1999). What price ergonomics?Nature, 399(6733), 197–198.
38.
StoneJ. A.WattersonT.XiongK. Z.RamlyE.KleinschmidtP.SeminakM.. . . ChuiM. A. (2020, 2020). Identifying Vulnerabilities in HealthIT: A Case Study of CancelRx Implementation in Clinic and Pharmacy Sociotechnical Systems.
39.
TrauerJ. M.QianM. Y.DoyleJ. S.RajaratnamS. M. W.CunningtonD. (2015). Cognitive Behavioral Therapy for Chronic Insomnia: A Systematic Review and Meta-analysis. Annals of Internal Medicine, 163(3), 191–204.
40.
van MaanenA.MeijerA. M.van der HeijdenK. B.OortF. J. (2016). The effects of light therapy on sleep problems: A systematic review and meta-analysis. Sleep Medicine Reviews, 29, 52–62.
41.
WallisK. A.AndrewsA.HendersonM. (2017). Swimming Against the Tide: Primary Care Physicians’ Views on Deprescribing in Everyday Practice. Annals of Family Medicine, 15(4), 341–346.
42.
WattersonTAStoneJABrownR, et al. (Accepted). CancelRx: A Health IT Tool to Reduce Medication Discrepancies in the Outpatient Setting. Accepted to the Journal of the American Medical Informatics Association.
43.
WattersonTXiongKZStoneJARamlyEChuiMA. (2020). CancelRx: Comparing Front-Line and Leadership Perceptions of Health IT Implementation Using Quantitative Ethnography. American Pharmacists Association 2020 Annual Meeting and Exposition; National Harbor, MD.
44.
WattersonT.XiongK.StoneJ.RamlyE.CraddockL.YoungA.. . . ChuiM. (2018, 2018). Implementing CancelRx: Describing adoption barriers using a process map framework. Paper presented at the 11th Annual Conference on the Science of Dissemination and Implementation, Washington, DC.
45.
WeickK. E.SutcliffeK. M.ObstfeldD. (2005). Organizing and the process of sensemaking. Organizational Science, 16(4), 409–421.
46.
XiaoY.AbebeE.GursesA. (2019). Engineering a Foundation for Partnership to Improve Medication Safety during Care Transitions. Journal of Patient Safety and Risk Management, 24(1), 30–36.
47.
XiaoY.YoungR. (2021). Foreword. In HoldenR. J.ValdezR. S. (Eds.), The Patient Factor: Theories and Methods for Patient Ergonomics (pp. xi-xvii). Boca Raton, FL: CRC Press.
48.
XiongK.WattersonT.StoneJ.ChuiM. (2019, 2019). Unintended consequences of CancelRx. Paper presented at the 12th Annual Conference on the Science of Dissemination and Implementation, Arlington, VA.
